Moment analysis of intravenous, intraduodenal, buccal, rectal and percutaneous nifedipine in rats

Journal of Pharmacobio-Dynamics

Volumn 10, Issue 9, 1987, Pages 462-469

  Kondo, Shuji ^a   Sugimoto, Isao ^a  

^a KANEBO LTD   (Japan)

Author keywords

administration route; bioavailability; buccal administration; intraduodenal administration; intravenous administration; nifedipine; percutaneous administration; pharmacokinetics; rat; rectal administration

Indexed keywords

NIFEDIPINE;

ANIMAL EXPERIMENT; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RECTAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, BUCCAL; ADMINISTRATION, RECTAL; ADMINISTRATION, TOPICAL; ANIMAL; DUODENUM; INJECTIONS, INTRAVENOUS; INTUBATION, GASTROINTESTINAL; MALE; NIFEDIPINE; RATS;

EID: 0023629955     PISSN: 0386846X     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb1978.10.462     Document Type: Article

References (25)

1. E. M. Sorkin, S. P. Clissold, and R. N. Brogden: Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in is-chaemic heart disease, hypertension and related cardiovascular disorders, Drugs, 30, 182–274 (1985).
2. H. Echizen and M. Eichelbaum: Clinical pharmacokinetics of verpamil, nifedipine and diltiazem, Clin. Pharmacokinet., 11, 425–449 (1986).
3. O. Banzet, J. N. Colin, M. Thibonnier, E. Singlas, J. M. Alexandre, and P. Corvol: Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine, Eur. J. Clin. Pharmacol., 24, 145–150 (1983).
4. C. H. Kleinbloesem, P. Van Brummelen, J. A. Van de Linde, and D. D. Breimer: Pharmacokinetics of nifedipine in relation to pharmacological effects. A study in healthy volunteers wirh three different pharmaceutical formulations, Labo-Pharma-Probl. Tech., 31, 951 (1983).
5. S. Kondo, A. Kuchiki, K. Yamamoto, K. Akimoto, K. Takahashi, N. Awata, and I. Sugimoto: Identification of nifedipine metabolites and their determination by gas chromatography, Chem. Pharm. Bull., 28, 1–7 (1980).
6. S. Higuchi and Y. Shiobara: Quantitative determination of nifedipine in human plasma by selected ion monitoring, Biomed. Mass Spectrom., 5, 220–223 (1978).
7. Y. Tokuma, T. Fujiwara, and H. Noguchi: Determination of nilvadipine in human plasma by capillary column gas chromatography negative-ion chemical-ionization mass spectrometry, J. Chromatogr., 345, 51–58 (1985);
8. idem: Combined capillary column gas chromatography/electron capture negative ion chemical ionization mass spectrometry of dihydropyridine calcium antagonists, Biomed. Mass Spectrom., 13, 251–255 (1986).
9. R. Testa, E. Dolfini, C. Reschiotto, C. Secchi, and P. A. Biondi: GLC determination of nifedipine, a light sensi tive drug, in plasma, Farmaco Ed. Prat, 34, 465–473 (1979).
10. S. Higuchi and S. Kawamura: Specific determination of plasma nicardipine hydrochloride levels by gas chromatography-mass spectrometry, J. Chromatogr., 223, 341–349 (1981).
11. T. Murayama, G. Izu, Y. Furuta, Y. Hashimoto, M. Ishibashi, and H. Miyazaki: Abstracts of Papers, 103rd Annual Meeting of Pharmaceutical Society of Japan, Tokyo, April 1983, p. 539.
12. K. Yamaoka, T. Nakagawa, and T. Uno: Statistical moments in pharmacokinetics, J. Pharmacokinet. Bio-pharm., 6, 547–558 (1978).
13. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno: A pharmacokinetic analysis program (MULTI) for microcomputer, J. Pharmacobio-Dyn., 4, 879–885 (1981);
14. K. Yamaoka and Y. Tanigawara: “Yakubutu-sokudoron-nyumon,” Nankodo, Tokyo, 1983;
15. K. Yamaoka: “Yakubutu-tainaidotai-kaise-kiho,” Nankodo, Tokyo, 1984.
16. M. Gibaldi and D. Perrier: Noncompartmental analysis based on statistical moment theory, “Pharmacokinetics,” 2nd ed., Marcel Dekker, Inc., New York, N. Y., 1982, pp. 409–417.
17. K. B. Bischoff, R. L. Dedric, D. S. Zaharko, and J. A. Longstreth: Methotrexate pharmacokinetics, J. Pharm. Sci., 60, 1128–1133 (1971).
18. L. D. Raemsch: Zur Pharmakokinetik von Nifedipine, SchwerpunktMedizin, 4, 55–61 (1981).
19. C. H. Kleinbloesem, P. van Brummelen, J. van Harten, M. Danhof, and D. D. Breimer: Nifedipine. Influence of renal function on pharmacokinetic/hemodynamic relationship, Clin. Pharmacol. Ther., 37, 563–574 (1985);
20. C. H. Kleinbloesem, P. van Brummelen, J. Hillers, A. J. Moolenaar, and D. D. Breimer: Interaction between digoxin and nifedipine at steady state in patients with arterial fibrillation, Ther. DrugMonit., 7, 372–376 (1985).
21. B. Von Duhm, W. Maul, H. Medenwald, K. Patzschke, und L. A. Wegner: Tierexperimentelle Untersuchung-en zur Pharmakokinetik und Biotransformation von radioaktiv markiertem 4-(2'-Nitrophenyl)-2, 6-di-methyl-1, 4-dihydropyridin-3, 5-dicarbonsauredime-thylester, Arzneim. -Forsch., 22, 42–52 (1972).
22. L. Z. Benet: The effect of route of administration and distribution on drug action, “Modern Pharmaceutics,” ed. by G. S. Banker and C. T. Rhodes, Marcel Dekker Inc., New York, N. Y. 1979, Chapter 5.
23. K. Ueda, A. Takahashi, T. Kikuiri, N. Kurosawa, E. Ohwada, and K. Ito, Abstracts of Papers, 104th Annual Meeting of Pharmaceutical Society of Japan, Sendai, March 1984, p. 759.
24. Y. Tanigawara, K. Yamaoka, T. Nakagawa, and T. Uno: Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products, J. Pharm. Sci., 71, 1129–1133 (1982).
25. S. Kondo and I. Sugimoto: Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier, J. Pharmacobio-Dyn., accepted.